Nasdaq:US$36.45 (-2.83) | HKEX:HK$60.55 (-6.40) | AIM:£5.37 (-0.28)
新聞中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科學出版物 | 2010-11-30

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)